Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
Journal of the American Chemical Society · 05.03.2025 · 147 (9) · 7161-7181
DOI: 10.1021/jacs.4c18328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Chemical Society, online erschienen am 20.02.2025. Verfasst von Ashish Kumar Yadav und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh 221005, India. Hauptthemen laut MEDLINE: NAD, Antineoplastic Agents, Neoplasms, NADP. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: Science and Engineering Research Board, Ministry of Education, India.
Abstract (Originalsprache)
Photocatalytic cancer therapy (PCT) has emerged as a cutting-edge anticancer mechanism of action, harnessing light energy to mediate the catalytic oxidation of intracellular substrates. PCT is of significant current importance due to its potential to address the limitations of conventional chemotherapy, particularly drug resistance and side effects. This approach offers a noninvasive, targeted cancer treatment option by utilizing metal-based photocatalysts to induce redox and metabolic disorders within cancer cells. The photocatalysts disrupt the cancer cell metabolism by converting NADH/NAD(P)H to NAD+/NAD(P)+ via catalytic photoredox processes, altering intracellular NAD+/NADH or NAD(P)+/NAD(P)H ratios, which are crucial for cellular metabolism. Ir(III), Ru(II), Re(I), and Os(II) photocatalysts demonstrated promising PCT efficacy. Despite these developments, gaps remain in the literature for translating this new anticancer mechanism into clinical trials. This Perspective critically examines the developments in this research area and provides future directions for designing efficient photocatalysts for PCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh 221005, India.
ORCID-Profile: Samya Banerjee
Förderung
- Science and Engineering Research Board
- Ministry of Education, India
Zitieren
APA
Yadav, A. K., Kushwaha, R., Mandal, A. A., Mandal, A., & Banerjee, S. (2025). Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development. Journal of the American Chemical Society, 147(9), 7161-7181. https://doi.org/10.1021/jacs.4c18328
Vancouver
Yadav AK, Kushwaha R, Mandal AA, Mandal A, Banerjee S. Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development. Journal of the American Chemical Society. 2025;147(9):7161-7181. doi:10.1021/jacs.4c18328
BibTeX
@article{Yadav2025,
author = {Yadav, Ashish Kumar and Kushwaha, Rajesh and Mandal, Arif Ali and Mandal, Apurba and Banerjee, Samya},
title = {Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {9},
pages = {7161--7181},
doi = {10.1021/jacs.4c18328}
}
EUVIMED